loadpatents
name:-0.02128791809082
name:-0.0099198818206787
name:-0.0051329135894775
Celatka; Cassandra Patent Filings

Celatka; Cassandra

Patent Applications and Registrations

Patent applications and USPTO patent grants for Celatka; Cassandra.The latest application filed is for "kdm1a inhibitors for the treatment of disease".

Company Profile
5.10.20
  • Celatka; Cassandra - Hull MA
  • Celatka; Cassandra - Chesterfield MA
  • Celatka; Cassandra - Waltham MA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods and processes for the preparation of KDM1A inhibitors
Grant 11,390,590 - Tapper , et al. July 19, 2
2022-07-19
Kdm1a Inhibitors For The Treatment Of Disease
App 20220073477 - RIENHOFF, JR.; Hugh Y. ;   et al.
2022-03-10
Glucosylceramide Synthase Inhibitors
App 20220073508 - BOURQUE; Elyse ;   et al.
2022-03-10
Compositions And Methods For Producing Stereoisomerically Pure Aminocyclopropanes
App 20220025424 - TAPPER; Amy E. ;   et al.
2022-01-27
KDM1A inhibitors for the treatment of disease
Grant 11,230,534 - Rienhoff, Jr. , et al. January 25, 2
2022-01-25
Glucosylceramide Synthase Inhibitors
App 20210261557 - BOURQUE; Elyse ;   et al.
2021-08-26
Glucosylceramide synthase inhibitors
Grant 11,008,316 - Bourque , et al. May 18, 2
2021-05-18
Methods And Processes For The Preparation Of Kdm1a Inhibitors
App 20210139437 - TAPPER; Amy E. ;   et al.
2021-05-13
Kdm1a Inhibitors For The Treatment Of Disease
App 20210115023 - TAPPER; Amy E. ;   et al.
2021-04-22
Kdm1a Inhibitors For The Treatment Of Disease
App 20200283397 - RIENHOFF, JR.; Hugh Y. ;   et al.
2020-09-10
Glucosylceramide Synthase Inhibitors
App 20200048266 - BOURQUE; Elyse ;   et al.
2020-02-13
KDM1A inhibitors for the treatment of disease
Grant 10,519,118 - Rienhoff, Jr. , et al. Dec
2019-12-31
Kdm1a Inhibitors For The Treatment Of Disease
App 20180312474 - RIENHOFF, Jr.; Hugh Y. ;   et al.
2018-11-01
KDM1A inhibitors for the treatment of disease
Grant 9,981,922 - Rienhoff, Jr. , et al. May 29, 2
2018-05-29
Glucosylceramide Synthase Inhibitors
App 20180065957 - BOURQUE; Elyse ;   et al.
2018-03-08
Kdm1a Inhibitors For The Treatment Of Disease
App 20160237043 - Rienhoff, JR.; Hugh Y. ;   et al.
2016-08-18
Glucosylceramide Synthase Inhibitors
App 20160207933 - BOURQUE; Elyse ;   et al.
2016-07-21
Glucosylceramide Synthase Inhibitors
App 20150210681 - Bourque; Elyse ;   et al.
2015-07-30
2-aminoindole compounds and methods for the treatment of malaria
Grant 8,980,926 - Mazitschek , et al. March 17, 2
2015-03-17
Glucosylceramide Synthase Inhibitors
App 20140371460 - BOURQUE; Elyse ;   et al.
2014-12-18
Glucosylceramide Synthase Inhibitors
App 20140255381 - BOURQUE; Elyse ;   et al.
2014-09-11
Inhibitors of S-adenosyl-L-methionine decarboxylase
Grant 8,633,168 - Xiang , et al. January 21, 2
2014-01-21
2-Aminoindole Compounds And Methods For The Treatment Of Malaria
App 20120232063 - Mazitschek; Ralph ;   et al.
2012-09-13
Inhibitors Of S-adenosyl-l-methionine Decarboxylase
App 20100261668 - Xiang; Yibin ;   et al.
2010-10-14
Substituted Azetidinones
App 20100144698 - Bannister; Thomas ;   et al.
2010-06-10
Substituted Azetidinones
App 20090143351 - Bannister; Thomas ;   et al.
2009-06-04
Substituted azetidinones
Grant 7,501,404 - Bannister , et al. March 10, 2
2009-03-10
Substituted azetidinones
App 20070105832 - Bannister; Thomas ;   et al.
2007-05-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed